JCF Intersections

🔗 bit.ly/3NzhViZ

Another view urges caution: CS care is time-sensitive, & assembling teams could delay treatment. Clear, evidence-based protocols may be just as important as the team itself. The future likely lies in combining structured pathways with multidisciplinary care.⚖️ 🧵👇

Should cardiogenic shock teams become the standard of care? It's up for debate!🫀 One viewpoint argues yes: multidisciplinary shock teams can streamline diagnosis, coordinate care & improve outcomes across institutions. Observational data support their impact. 🧵👇

tMCS (e.g., VA-ECMO) can save lives—but what if there’s no path forward? A new perspective examines the ethical challenge of the “bridge to nowhere” and explores concepts like dynamic consent, moral distress, distributive justice, and so much more⚖️🫀 🔗 bit.ly/41oRsrt

LVAD offers a stable platform to help patients overcome barriers to heart transplant. In one cohort, ~70% had modifiable barriers and 60% of these resolved at least one after LVAD, highlighting the role of multidisciplinary care.🫀📊 🔗 bit.ly/4uPEHUy

Cardiogenic shock → low CO & end-organ hypoperfusion. LV failure is common, but don’t miss other causes: valvular disease, mechanical MI complications, or RV failure. A systematic approach + bedside echo can rapidly guide diagnosis and escalation.🫀 🔗 bit.ly/4uPBSTs

JCF Intersections is out now! Where research meets perspective, and new ideas take shape across disciplines. Explore the latest 👉 onlinejcfi.org/current #HeartFailure #Cardiology

@noshreza @JasonKatzMD @SarahChuzi @JulieDoberne @ShahzebKhanMD @ElliottMillerMD @hcg_md @dranulala @robmentz 🔗 bit.ly/3ZmjsLp

A HFrEF polypill💊 could ⬆️ GDMT uptake, but prescriber prefs are unknown. Using a 5-stage mixed-methods process, researchers built a discrete choice experiment to test cardiologists’ prefs—work that will directly inform future HFrEF polypill clinical trials. Read more 👇

New science 🚨! In an analysis of centrifugal-flow LVAD trials, digoxin💊 users showed greater improvement in 6MWT 🚶 vs no digoxin (especially in older pts) with similar QOL & AE rates. Digoxin was also linked to better 4-yr survival in NICM pts. 🔗 bit.ly/4r5phsy

📣 Last chance to register for JCF-I Office Hours! Join Editor in Chief Dr. Katz and Deputy Editor Dr. Reza to answer your questions on: ✅ JCF-I's upcoming publications ✅ What they are looking for in submissions ✅ Updates on the year ahead bit.ly/3NmOKz4

The January issue of JCF-I is now available 👉 bringing forward new evidence, perspectives, and conversations in heart failure + various intersections. Read the full issue 📖onlinejcfi.org/current

Time is running out! Register for JCF-I Office Hours⌛ Join Editor in Chief Dr. Katz and Deputy Editor Dr. Reza to answer your questions on: ✅ JCF-I's upcoming publications ✅ What they are looking for in submissions ✅ Updates on the year ahead bit.ly/3NmOKz4

🚨 JCF-I Office Hours Join Editor in Chief Dr. Katz and Deputy Editor Dr. Reza to answer your questions on: ✅ JCF-I's upcoming publications ✅ What they are looking for in submissions ✅ Updates on the year ahead Register: bit.ly/3NmOKz4

Overall, meaningful weight loss and potential cardiac benefits. Read more 👉 bit.ly/3Ka9yZz

🍽️ Key Highlights -125 overweight/obese HF patients Rx LCKD were followed for avg 2 years -Median weight loss: 11.2 kg (p<0.01) -No ⬇️ in EF -Significant ⬇️ in HF 🏥 in HFpEF, numerically lower in HFrEF -LCKD was safe, with improvements in several metabolic markers

📢 New study in JCF-I on the safety and effectiveness of a low-carbohydrate ketogenic diet LCKD for weight loss in patients with overweight/obesity and HF. This is one of the largest real-world looks at LCKD use in HF. 🫀🍽️ See below ⬇️ bit.ly/3Ka9yZz

Measuring RVR offers prognostic insight across cardiopulmonary diseases, but definitions and testing methods remain inconsistent. 🔗 Read in Journal of Cardiac Failure – Intersections: bit.ly/3Kdvsef #HeartFailure #CardioTwitter #PulmonaryHypertension #PeoplesVentricle

How well can the right ventricle rise to the challenge? 💪💙 A new JCF-Intersections paper reviews right ventricular reserve (RVR) — the RV’s ability to boost output under stress. 🧵